ArticleFrontiers in oncology2023

Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial.

Cláudia S Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.